Jean-Claude Tardif Selected Research

COVID-19

1/2023	Potassium reduction with sodium zirconium cyclosilicate in patients with heart failure.
1/2023	Response to: 'Correspondence on 'Anti-inflammatory therapy for COVID-19 infection: the case for colchicine'' by Perricone et al.
3/2022	Predictive risk factors for hospitalization and response to colchicine in patients with COVID-19.
1/2022	Hair cortisol change at COVID-19 pandemic onset predicts burnout among health personnel.
1/2022	Fourteen-Day Evolution of COVID-19 Symptoms during the Third Wave in Nonvaccinated Subjects and Effects of Hesperidin Therapy: A Randomized, Double-Blinded, Placebo-Controlled Study.
10/2021	Immunologic Dysregulation and Hypercoagulability as a Pathophysiologic Background in COVID-19 Infection and the Immunomodulating Role of Colchicine.
6/2021	Inhibition of the 3CL Protease and SARS-CoV-2 Replication by Dalcetrapib.
1/2021	Colchicine for community-treated patients with COVID-19 (COLCORONA): a phase 3, randomised, double-blinded, adaptive, placebo-controlled, multicentre trial.
1/2021	Anti-inflammatory therapy for COVID-19 infection: the case for colchicine.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jean-Claude Tardif Research Topics

Disease

67	Coronary Artery Disease (Coronary Atherosclerosis) 01/2024 - 01/2002
64	Myocardial Infarction 01/2024 - 01/2002
56	Atherosclerosis 01/2024 - 01/2002
54	Heart Failure 01/2023 - 05/2002
46	Inflammation (Inflammations) 03/2024 - 01/2002
44	Cardiovascular Diseases (Cardiovascular Disease) 03/2024 - 04/2004
39	Acute Coronary Syndrome 01/2024 - 03/2003
32	Stroke (Strokes) 11/2023 - 03/2004
32	Atrial Fibrillation 01/2023 - 05/2002
26	Fibrosis (Cirrhosis) 03/2024 - 06/2003
25	Atherosclerotic Plaque (Atheroma) 11/2021 - 11/2004
21	Type 2 Diabetes Mellitus (MODY) 01/2024 - 08/2011
21	Left Ventricular Dysfunction 01/2024 - 02/2003
17	Coronary Disease (Coronary Heart Disease) 01/2024 - 04/2006
14	Hypertension (High Blood Pressure) 01/2022 - 07/2004
11	Pulmonary Hypertension 03/2021 - 03/2004
10	Aortic Valve Stenosis (Aortic Stenosis) 01/2021 - 02/2014
9	Unstable Angina 11/2023 - 01/2005
9	COVID-19 01/2023 - 01/2021
9	Disease Progression 11/2019 - 01/2002
9	Stable Angina 09/2013 - 12/2005
8	Vascular Diseases (Vascular Disease) 03/2024 - 02/2003
8	Hypertriglyceridemia 09/2022 - 06/2008
8	Hemorrhage 12/2021 - 05/2008
7	Diabetes Mellitus 01/2024 - 03/2007
7	Cardiac Arrhythmias (Arrythmia) 01/2023 - 07/2004
7	Pathologic Constriction (Stenosis) 12/2020 - 12/2005
7	ST Elevation Myocardial Infarction 11/2020 - 10/2010
6	Metabolic Syndrome (Dysmetabolic Syndrome X) 11/2023 - 02/2006
6	Infections 01/2023 - 01/2005
6	Heart Diseases (Heart Disease) 01/2022 - 07/2004
6	Infarction (Infarctions) 01/2022 - 12/2007
6	Hypercholesterolemia 11/2021 - 01/2012
6	Dyslipidemias (Dyslipidemia) 01/2018 - 01/2010
6	Myocardial Ischemia (Ischemic Heart Diseases) 10/2017 - 01/2006
6	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 09/2012 - 08/2003
5	Bradycardia 10/2023 - 03/2009
5	Hypertrophy 01/2022 - 07/2016
5	Carotid Artery Diseases 01/2021 - 02/2003
5	Cardiomyopathies (Cardiomyopathy) 12/2019 - 07/2006
5	Obesity 07/2019 - 08/2015
5	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 07/2018 - 01/2012
4	Tachycardia (Tachyarrhythmias) 12/2023 - 08/2013
4	Cognitive Dysfunction 01/2023 - 01/2019
4	Gout 01/2022 - 12/2019
4	Pericarditis 01/2022 - 12/2019
4	Insulin Resistance 03/2021 - 08/2011
4	Heart Arrest (Cardiac Arrest) 01/2021 - 11/2012
4	Systolic Heart Failure 12/2019 - 08/2013

Drug/Important Bio-Agent (IBA)

40	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 03/2024 - 10/2002
29	LipidsIBA 01/2023 - 01/2005
25	Biomarkers (Surrogate Marker)IBA 04/2024 - 06/2006
24	Colchicine FDA LinkGeneric 01/2024 - 12/2019
24	IvabradineIBA 01/2020 - 12/2005
19	CholesterolIBA 01/2024 - 01/2005
18	LDL CholesterolIBA 03/2024 - 05/2008
16	Proteins (Proteins, Gene)FDA Link 01/2024 - 07/2006
14	eicosapentaenoic acid ethyl esterIBA 11/2023 - 01/2019
14	dalcetrapibIBA 01/2023 - 12/2009
14	HDL LipoproteinsIBA 01/2021 - 08/2006
13	HDL CholesterolIBA 01/2020 - 02/2006
13	AntioxidantsIBA 05/2008 - 01/2002
11	C-Reactive ProteinIBA 01/2022 - 04/2003
11	Glucose (Dextrose)FDA LinkGeneric 01/2017 - 03/2007
10	Triglycerides (Triacylglycerol)IBA 03/2024 - 03/2009
10	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 10/2022 - 05/2002
10	oxidized low density lipoproteinIBA 01/2022 - 01/2005
9	succinobucol (AGI 1067)IBA 05/2008 - 01/2002
8	Natriuretic PeptidesIBA 01/2023 - 05/2009
8	Cholesterol Ester Transfer ProteinsIBA 01/2023 - 12/2008
8	Lipoproteins (Lipoprotein)IBA 09/2022 - 01/2008
8	Apolipoprotein A-I (Apolipoprotein A1)IBA 01/2021 - 06/2008
8	Atorvastatin (Lipitor)FDA Link 04/2014 - 01/2005
8	Probucol (Lorelco)FDA Link 05/2006 - 01/2002
7	pro-brain natriuretic peptide (1-76)IBA 01/2024 - 09/2014
7	CalciumIBA 10/2023 - 04/2008
7	lixisenatideIBA 01/2023 - 05/2015
7	aleglitazarIBA 01/2022 - 09/2013
7	CollagenIBA 01/2020 - 01/2002
7	Phenobarbital (Luminal)FDA Link 05/2008 - 01/2002
6	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 06/2007 - 05/2002
5	salicylhydroxamic acid (SHAM)IBA 01/2024 - 08/2010
5	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 01/2022 - 12/2007
5	Interleukin-6 (Interleukin 6)IBA 01/2022 - 01/2013
5	Lipoprotein(a)IBA 01/2022 - 06/2014
5	ApolipoproteinsIBA 01/2018 - 02/2003
5	Enalapril FDA LinkGeneric 10/2006 - 05/2002
4	Messenger RNA (mRNA)IBA 01/2022 - 05/2009
4	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2022 - 09/2013
4	InterleukinsIBA 11/2021 - 01/2013
4	Warfarin (Coumadin)FDA LinkGeneric 01/2021 - 11/2005
4	AnticoagulantsIBA 01/2021 - 01/2015

Therapy/Procedure

95	Therapeutics 03/2024 - 01/2002
16	Percutaneous Coronary Intervention 01/2022 - 01/2002
10	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 10/2017 - 05/2006
8	Secondary Prevention 01/2022 - 07/2006
5	Stents 11/2021 - 01/2002
5	Cardiopulmonary Bypass (Heart-Lung Bypass) 10/2016 - 10/2006
5	Catheters 10/2015 - 03/2004
4	Drug Therapy (Chemotherapy) 12/2019 - 02/2005